speb/financial-data huggingface dataset:
COV.PA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 67700000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1083000000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 7500000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 110802799.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 200000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 36300000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: -100000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 20900000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: -100000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 36800000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Other Payable: 169200000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Other Properties: 130600000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Other Receivables: 197300000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 1100000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Payables: 590500000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 21100000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Raw Materials: 2600000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 341400000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Share Issued: 111623468.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 8222100000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 7876300000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 87500000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Total Assets: 25632600000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 16743500000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Total Debt: 11241500000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 12023200000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 13609400000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 22948800000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 10066200000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 138600000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 820669.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 23900000.00
COV.PA balance_sheet (quarterly, 2025-06-30) — Working Capital: -859400000.00
COV.PA income_statement (annual, 2025-12-31) — +Operating Expense: 159600000.00
COV.PA income_statement (annual, 2025-12-31) — +Total Revenue: 1395900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Accounts Payable: 195800000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 195800000.00
COV.PA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 226500000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 226500000.00
COV.PA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -914900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -914900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4187100000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4187100000.00
COV.PA balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -23000000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -23000000.00
COV.PA balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 435200000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 435200000.00
COV.PA balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 54700000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 54700000.00
COV.PA income_statement (annual, 2025-12-31) — Basic Average Shares: 110792690.00
COV.PA income_statement (annual, 2025-12-31) — Basic EPS: 6.67
COV.PA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1004200000.00
COV.PA balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 58300000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 58300000.00
COV.PA cash_flow (annual, 2025-12-31) — Capital Expenditure: -579600000.00
COV.PA balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 304400000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 304400000.00
COV.PA balance_sheet (annual, 2025-12-31) — Capital Stock: 334900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 334900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1207400000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1207400000.00
COV.PA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1207800000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1207800000.00
COV.PA cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -387600000.00
COV.PA balance_sheet (annual, 2025-12-31) — Cash Equivalents: 663900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 663900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Cash Financial: 543500000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Cash Financial: 543500000.00
COV.PA cash_flow (annual, 2025-12-31) — Change In Inventory: -37100000.00
COV.PA cash_flow (annual, 2025-12-31) — Change In Payable: -57000000.00
COV.PA cash_flow (annual, 2025-12-31) — Change In Receivables: -400000.00
COV.PA cash_flow (annual, 2025-12-31) — Change In Working Capital: -94500000.00
COV.PA cash_flow (annual, 2025-12-31) — Changes In Cash: 201600000.00
COV.PA balance_sheet (annual, 2025-12-31) — Common Stock: 334900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Common Stock: 334900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 8614200000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 8614200000.00
COV.PA cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1400000.00
COV.PA cash_flow (annual, 2025-12-31) — Common Stock Payments: -18800000.00
COV.PA income_statement (annual, 2025-12-31) — Cost Of Revenue: 396700000.00
COV.PA balance_sheet (annual, 2025-12-31) — Current Assets: 2566200000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Current Assets: 2566200000.00
COV.PA balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 8000000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 8000000.00
COV.PA balance_sheet (annual, 2025-12-31) — Current Debt: 1976600000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Current Debt: 1976600000.00
COV.PA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1984600000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1984600000.00
COV.PA balance_sheet (annual, 2025-12-31) — Current Liabilities: 2774500000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2774500000.00
COV.PA balance_sheet (annual, 2025-12-31) — Current Provisions: 3700000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Current Provisions: 3700000.00
COV.PA cash_flow (annual, 2025-12-31) — Deferred Tax: -195100000.00
COV.PA cash_flow (annual, 2025-12-31) — Depreciation: 144000000.00
COV.PA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 144000000.00
COV.PA income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 114400000.00
COV.PA income_statement (annual, 2025-12-31) — Depreciation Income Statement: 114400000.00
COV.PA balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 76400000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 76400000.00
COV.PA income_statement (annual, 2025-12-31) — Diluted Average Shares: 111437410.00
COV.PA income_statement (annual, 2025-12-31) — Diluted EPS: 6.63
COV.PA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 738700000.00
COV.PA balance_sheet (annual, 2025-12-31) — Dividends Payable: 100000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 100000.00
COV.PA cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 37800000.00
COV.PA income_statement (annual, 2025-12-31) — EBIT: 1226200000.00
COV.PA income_statement (annual, 2025-12-31) — EBITDA: 1370200000.00
COV.PA cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 600000.00
COV.PA cash_flow (annual, 2025-12-31) — End Cash Position: 1206400000.00
COV.PA balance_sheet (annual, 2025-12-31) — Financial Assets: 306900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Financial Assets: 306900000.00
COV.PA cash_flow (annual, 2025-12-31) — Financing Cash Flow: -532400000.00
COV.PA balance_sheet (annual, 2025-12-31) — Finished Goods: 397000000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Finished Goods: 397000000.00
COV.PA cash_flow (annual, 2025-12-31) — Free Cash Flow: 240000000.00
COV.PA cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -2300000.00
COV.PA balance_sheet (annual, 2025-12-31) — Goodwill: 324000000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Goodwill: 324000000.00
COV.PA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 344900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 344900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 249500000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 249500000.00
COV.PA balance_sheet (annual, 2025-12-31) — Gross PPE: 2881200000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2881200000.00
COV.PA income_statement (annual, 2025-12-31) — Gross Profit: 999200000.00
COV.PA balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 79800000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 79800000.00
COV.PA income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 31100000.00
COV.PA income_statement (annual, 2025-12-31) — Interest Expense: 261500000.00
COV.PA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 261500000.00
COV.PA income_statement (annual, 2025-12-31) — Interest Income: 33500000.00
COV.PA income_statement (annual, 2025-12-31) — Interest Income Non Operating: 33500000.00
COV.PA cash_flow (annual, 2025-12-31) — Interest Paid Cff: -149100000.00
COV.PA balance_sheet (annual, 2025-12-31) — Inventory: 400900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Inventory: 400900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Invested Capital: 19246000000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 19246000000.00
COV.PA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -85600000.00
COV.PA balance_sheet (annual, 2025-12-31) — Investment Properties: 19508500000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Investment Properties: 19508500000.00
COV.PA balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 54700000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 54700000.00
COV.PA balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 438800000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 438800000.00
COV.PA cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 1400000.00
COV.PA cash_flow (annual, 2025-12-31) — Issuance Of Debt: 2314100000.00
COV.PA balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 296400000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 296400000.00
COV.PA balance_sheet (annual, 2025-12-31) — Long Term Debt: 8655200000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 8655200000.00
COV.PA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 8951600000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 8951600000.00
COV.PA cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 2314100000.00
COV.PA cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2144900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 438800000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 438800000.00
COV.PA balance_sheet (annual, 2025-12-31) — Long Term Provisions: 46400000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 46400000.00
COV.PA balance_sheet (annual, 2025-12-31) — Minority Interest: 4036800000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Minority Interest: 4036800000.00
COV.PA income_statement (annual, 2025-12-31) — Minority Interests: -421100000.00
COV.PA cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 149100000.00
COV.PA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -17400000.00
COV.PA balance_sheet (annual, 2025-12-31) — Net Debt: 9424400000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Net Debt: 9424400000.00
COV.PA income_statement (annual, 2025-12-31) — Net Income: 738700000.00
COV.PA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 738700000.00
COV.PA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1159800000.00
COV.PA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 738700000.00
COV.PA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 738700000.00
COV.PA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1159800000.00
COV.PA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1159800000.00
COV.PA income_statement (annual, 2025-12-31) — Net Interest Income: -249700000.00
COV.PA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -200000.00
COV.PA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 169200000.00
COV.PA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 169200000.00
COV.PA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -249700000.00
COV.PA cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -38100000.00
COV.PA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 1700000.00
COV.PA balance_sheet (annual, 2025-12-31) — Net PPE: 1966300000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Net PPE: 1966300000.00
COV.PA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -288700000.00
COV.PA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 8269300000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 8269300000.00
COV.PA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 62900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 62900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 799600000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 799600000.00
COV.PA balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 5200000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 5200000.00
COV.PA income_statement (annual, 2025-12-31) — Normalized EBITDA: 1346300000.00
COV.PA income_statement (annual, 2025-12-31) — Normalized Income: 720775000.00
COV.PA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 819600000.00
COV.PA income_statement (annual, 2025-12-31) — Operating Income: 839600000.00
COV.PA income_statement (annual, 2025-12-31) — Operating Revenue: 1395900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 110728131.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 110728131.00
COV.PA balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 48800000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 48800000.00
COV.PA balance_sheet (annual, 2025-12-31) — Other Equity Interest: 100000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 100000.00
COV.PA balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 20900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 20900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Other Inventories: -100000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Other Inventories: -100000.00
COV.PA cash_flow (annual, 2025-12-31) — Other Non Cash Items: -145900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 100000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 100000.00
COV.PA balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 38600000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 38600000.00
COV.PA income_statement (annual, 2025-12-31) — Other Operating Expenses: 133500000.00
COV.PA balance_sheet (annual, 2025-12-31) — Other Payable: 119900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Other Payable: 119900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Other Properties: 2822900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Other Properties: 2822900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Other Receivables: 104000000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Other Receivables: 104000000.00
COV.PA balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 400000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 400000.00
COV.PA income_statement (annual, 2025-12-31) — Other Special Charges: 1400000.00
COV.PA income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
COV.PA balance_sheet (annual, 2025-12-31) — Payables: 410200000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Payables: 410200000.00
COV.PA balance_sheet (annual, 2025-12-31) — Prepaid Assets: 32600000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 32600000.00
COV.PA income_statement (annual, 2025-12-31) — Pretax Income: 964700000.00
COV.PA balance_sheet (annual, 2025-12-31) — Properties: 0.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
COV.PA cash_flow (annual, 2025-12-31) — Purchase Of Investment: -200000.00
COV.PA cash_flow (annual, 2025-12-31) — Purchase Of PPE: -579600000.00
COV.PA balance_sheet (annual, 2025-12-31) — Raw Materials: 4000000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Raw Materials: 4000000.00
COV.PA income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 396700000.00
COV.PA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 144000000.00
COV.PA income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 24300000.00
COV.PA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2144900000.00
COV.PA cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -18800000.00
COV.PA balance_sheet (annual, 2025-12-31) — Retained Earnings: 738700000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 738700000.00
COV.PA cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
COV.PA cash_flow (annual, 2025-12-31) — Sale Of PPE: 290900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Share Issued: 111623468.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Share Issued: 111623468.00
COV.PA income_statement (annual, 2025-12-31) — Special Income Charges: -35800000.00
COV.PA cash_flow (annual, 2025-12-31) — Stock Based Compensation: 6900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 8614200000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 8614200000.00
COV.PA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 8269300000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 8269300000.00
COV.PA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 5975000.00
COV.PA income_statement (annual, 2025-12-31) — Tax Provision: -195100000.00
COV.PA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
COV.PA balance_sheet (annual, 2025-12-31) — Taxes Receivable: 79400000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 79400000.00
COV.PA cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -33600000.00
COV.PA balance_sheet (annual, 2025-12-31) — Total Assets: 25338100000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Total Assets: 25338100000.00
COV.PA balance_sheet (annual, 2025-12-31) — Total Capitalization: 17269400000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 17269400000.00
COV.PA balance_sheet (annual, 2025-12-31) — Total Debt: 10936200000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Total Debt: 10936200000.00
COV.PA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 12651000000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 12651000000.00
COV.PA income_statement (annual, 2025-12-31) — Total Expenses: 556300000.00
COV.PA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 12687100000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 12687100000.00
COV.PA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 22771900000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 22771900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 9912600000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 9912600000.00
COV.PA income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1134700000.00
COV.PA income_statement (annual, 2025-12-31) — Total Other Finance Cost: 21700000.00
COV.PA balance_sheet (annual, 2025-12-31) — Total Tax Payable: 94400000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 94400000.00
COV.PA income_statement (annual, 2025-12-31) — Total Unusual Items: 23900000.00
COV.PA income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 23900000.00
COV.PA balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 895337.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 895337.00
COV.PA balance_sheet (annual, 2025-12-31) — Treasury Stock: 34500000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 34500000.00
COV.PA balance_sheet (annual, 2025-12-31) — Working Capital: -208300000.00
COV.PA balance_sheet (quarterly, 2025-12-31) — Working Capital: -208300000.00
COV.PA income_statement (annual, 2025-12-31) — Write Off: 3300000.00
COV.V cash_flow (annual, 2021-09-30) — Cash Dividends Paid: 0.00
COV.V cash_flow (annual, 2021-09-30) — Cash Flow From Discontinued Operation: 26617360.00
COV.V cash_flow (annual, 2021-09-30) — Common Stock Payments: 0.00
COV.V income_statement (annual, 2021-09-30) — Interest Expense: 419379.00
COV.V income_statement (annual, 2021-09-30) — Interest Expense Non Operating: 419379.00
COV.V cash_flow (annual, 2021-09-30) — Interest Paid Cff: -293175.00
COV.V cash_flow (annual, 2021-09-30) — Net Common Stock Issuance: 0.00
COV.V income_statement (annual, 2021-09-30) — Net Income Discontinuous Operations: 23057942.00
COV.V cash_flow (annual, 2021-09-30) — Net Other Investing Changes: -100869.00
COV.V balance_sheet (annual, 2021-09-30) — Non Current Deferred Liabilities: 162448.00
COV.V balance_sheet (annual, 2021-09-30) — Non Current Deferred Revenue: 162448.00
COV.V balance_sheet (annual, 2021-09-30) — Other Non Current Assets: 137061.00
COV.V cash_flow (annual, 2021-09-30) — Repurchase Of Capital Stock: 0.00
COV.V balance_sheet (annual, 2021-09-30) — Restricted Cash: 2548200.00
COV.V cash_flow (annual, 2021-09-30) — Sale Of PPE: 0.00
COV.V income_statement (annual, 2022-09-30) — +Operating Expense: 16635833.00
COV.V income_statement (annual, 2022-09-30) — +Total Revenue: 18146390.00
COV.V balance_sheet (annual, 2022-09-30) — Accounts Receivable: 4732430.00
COV.V balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -1839996.00
COV.V balance_sheet (annual, 2022-09-30) — Additional Paid In Capital: 11277493.00
COV.V cash_flow (annual, 2022-09-30) — Amortization Cash Flow: 156296.00
COV.V cash_flow (annual, 2022-09-30) — Amortization Of Intangibles: 156296.00
COV.V income_statement (annual, 2022-09-30) — Basic Average Shares: 25759555.00
COV.V income_statement (annual, 2022-09-30) — Basic EPS: -0.36
COV.V cash_flow (annual, 2022-09-30) — Beginning Cash Position: 22946923.00
COV.V balance_sheet (annual, 2022-09-30) — Buildings And Improvements: 656727.00
COV.V cash_flow (annual, 2022-09-30) — Capital Expenditure: -1081752.00
COV.V balance_sheet (annual, 2022-09-30) — Capital Lease Obligations: 2168641.00
COV.V balance_sheet (annual, 2022-09-30) — Capital Stock: 43843344.00
COV.V balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 14061631.00
COV.V balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Short Term Investments: 14061631.00
COV.V cash_flow (annual, 2022-09-30) — Cash Dividends Paid: 0.00
COV.V cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Financing Activities: -2186138.00
COV.V cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Investing Activities: -843023.00
COV.V cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Operating Activities: -7993570.00
COV.V cash_flow (annual, 2022-09-30) — Cash Flow From Discontinued Operation: 688522.00
COV.V cash_flow (annual, 2022-09-30) — Change In Inventory: -63367.00
COV.V cash_flow (annual, 2022-09-30) — Change In Other Working Capital: -248212.00
COV.V cash_flow (annual, 2022-09-30) — Change In Payables And Accrued Expense: -444207.00
COV.V cash_flow (annual, 2022-09-30) — Change In Prepaid Assets: -1169683.00
COV.V cash_flow (annual, 2022-09-30) — Change In Receivables: 1842085.00
COV.V cash_flow (annual, 2022-09-30) — Change In Working Capital: -83384.00
COV.V cash_flow (annual, 2022-09-30) — Changes In Account Receivables: 1842085.00
COV.V cash_flow (annual, 2022-09-30) — Changes In Cash: -10334209.00
COV.V balance_sheet (annual, 2022-09-30) — Common Stock: 43843344.00
COV.V balance_sheet (annual, 2022-09-30) — Common Stock Equity: 24228761.00
COV.V cash_flow (annual, 2022-09-30) — Common Stock Payments: -1726954.00
COV.V income_statement (annual, 2022-09-30) — Cost Of Revenue: 10652885.00
COV.V balance_sheet (annual, 2022-09-30) — Current Assets: 27228057.00
COV.V balance_sheet (annual, 2022-09-30) — Current Capital Lease Obligation: 609578.00
COV.V balance_sheet (annual, 2022-09-30) — Current Debt And Capital Lease Obligation: 609578.00
COV.V balance_sheet (annual, 2022-09-30) — Current Deferred Liabilities: 209070.00
COV.V balance_sheet (annual, 2022-09-30) — Current Deferred Revenue: 209070.00
COV.V balance_sheet (annual, 2022-09-30) — Current Liabilities: 4538856.00
COV.V cash_flow (annual, 2022-09-30) — Depreciation: 876512.00
COV.V cash_flow (annual, 2022-09-30) — Depreciation Amortization Depletion: 1032808.00
COV.V cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 1032808.00
COV.V income_statement (annual, 2022-09-30) — Diluted Average Shares: 25759555.00
COV.V income_statement (annual, 2022-09-30) — Diluted EPS: -0.36
COV.V income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: -9663213.00
COV.V income_statement (annual, 2022-09-30) — EBIT: -9142328.00
COV.V income_statement (annual, 2022-09-30) — EBITDA: -8109520.00
COV.V cash_flow (annual, 2022-09-30) — Effect Of Exchange Rate Changes: 1448917.00
COV.V cash_flow (annual, 2022-09-30) — End Cash Position: 14061631.00
COV.V cash_flow (annual, 2022-09-30) — Financing Cash Flow: -2186138.00
COV.V balance_sheet (annual, 2022-09-30) — Finished Goods: 6337693.00
COV.V balance_sheet (annual, 2022-09-30) — Foreign Currency Translation Adjustments: 3013209.00
COV.V cash_flow (annual, 2022-09-30) — Free Cash Flow: -9075322.00
COV.V cash_flow (annual, 2022-09-30) — Gain Loss On Sale Of PPE: -11311.00
COV.V balance_sheet (annual, 2022-09-30) — Gains Losses Not Affecting Retained Earnings: 3013209.00
COV.V income_statement (annual, 2022-09-30) — General And Administrative Expense: 6687980.00
COV.V balance_sheet (annual, 2022-09-30) — Goodwill And Other Intangible Assets: 1277327.00
COV.V balance_sheet (annual, 2022-09-30) — Gross PPE: 3712693.00
COV.V income_statement (annual, 2022-09-30) — Gross Profit: 7493505.00
COV.V income_statement (annual, 2022-09-30) — Interest Expense: 111590.00
COV.V income_statement (annual, 2022-09-30) — Interest Expense Non Operating: 111590.00
COV.V cash_flow (annual, 2022-09-30) — Interest Paid Cff: 0.00
COV.V balance_sheet (annual, 2022-09-30) — Inventories Adjustments Allowances: -2896108.00
COV.V balance_sheet (annual, 2022-09-30) — Inventory: 4965668.00
COV.V balance_sheet (annual, 2022-09-30) — Invested Capital: 24228761.00
COV.V cash_flow (annual, 2022-09-30) — Investing Cash Flow: -843023.00
COV.V cash_flow (annual, 2022-09-30) — Issuance Of Debt: 0.00
COV.V balance_sheet (annual, 2022-09-30) — Leases: 377492.00
COV.V balance_sheet (annual, 2022-09-30) — Long Term Capital Lease Obligation: 1559063.00
COV.V balance_sheet (annual, 2022-09-30) — Long Term Debt And Capital Lease Obligation: 1559063.00
COV.V cash_flow (annual, 2022-09-30) — Long Term Debt Issuance: 0.00
COV.V cash_flow (annual, 2022-09-30) — Long Term Debt Payments: -585184.00
COV.V balance_sheet (annual, 2022-09-30) — Machinery Furniture Equipment: 689748.00
COV.V cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: -1726954.00
COV.V income_statement (annual, 2022-09-30) — Net Income: -9663213.00
COV.V income_statement (annual, 2022-09-30) — Net Income Common Stockholders: -9663213.00
COV.V income_statement (annual, 2022-09-30) — Net Income Continuous Operations: -9253918.00
COV.V income_statement (annual, 2022-09-30) — Net Income Discontinuous Operations: -409295.00
COV.V income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: -9663213.00
COV.V income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: -9253918.00
COV.V cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: -9253918.00
COV.V income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: -9663213.00
COV.V cash_flow (annual, 2022-09-30) — Net Intangibles Purchase And Sale: -481908.00
COV.V income_statement (annual, 2022-09-30) — Net Interest Income: -111590.00
COV.V cash_flow (annual, 2022-09-30) — Net Issuance Payments Of Debt: -585184.00
COV.V cash_flow (annual, 2022-09-30) — Net Long Term Debt Issuance: -585184.00
COV.V income_statement (annual, 2022-09-30) — Net Non Operating Interest Income Expense: -111590.00
COV.V cash_flow (annual, 2022-09-30) — Net Other Investing Changes: 137061.00
COV.V balance_sheet (annual, 2022-09-30) — Net PPE: 1872697.00
COV.V cash_flow (annual, 2022-09-30) — Net PPE Purchase And Sale: -498176.00
COV.V balance_sheet (annual, 2022-09-30) — Net Tangible Assets: 22951434.00
COV.V balance_sheet (annual, 2022-09-30) — Non Current Deferred Liabilities: 51401.00
COV.V balance_sheet (annual, 2022-09-30) — Non Current Deferred Revenue: 51401.00
COV.V income_statement (annual, 2022-09-30) — Normalized EBITDA: -8109520.00
COV.V income_statement (annual, 2022-09-30) — Normalized Income: -9253918.00
COV.V cash_flow (annual, 2022-09-30) — Operating Cash Flow: -7993570.00
COV.V cash_flow (annual, 2022-09-30) — Operating Gains Losses: -11311.00
COV.V income_statement (annual, 2022-09-30) — Operating Income: -9142328.00
COV.V income_statement (annual, 2022-09-30) — Operating Revenue: 18146390.00
COV.V balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 25287777.00
COV.V income_statement (annual, 2022-09-30) — Other Gand A: 6687980.00
COV.V balance_sheet (annual, 2022-09-30) — Other Intangible Assets: 1277327.00
COV.V cash_flow (annual, 2022-09-30) — Other Non Cash Items: 110797.00
COV.V income_statement (annual, 2022-09-30) — Other Operating Expenses: 2064808.00
COV.V balance_sheet (annual, 2022-09-30) — Other Properties: 1988726.00
COV.V balance_sheet (annual, 2022-09-30) — Payables And Accrued Expenses: 3720208.00
COV.V balance_sheet (annual, 2022-09-30) — Prepaid Assets: 2097628.00
COV.V income_statement (annual, 2022-09-30) — Pretax Income: -9253918.00
COV.V cash_flow (annual, 2022-09-30) — Proceeds From Stock Option Exercised: 126000.00
COV.V balance_sheet (annual, 2022-09-30) — Properties: 0.00
COV.V cash_flow (annual, 2022-09-30) — Purchase Of Intangibles: -481908.00
COV.V cash_flow (annual, 2022-09-30) — Purchase Of PPE: -599844.00
COV.V balance_sheet (annual, 2022-09-30) — Raw Materials: 1524083.00
COV.V balance_sheet (annual, 2022-09-30) — Receivables: 4732430.00
COV.V income_statement (annual, 2022-09-30) — Reconciled Cost Of Revenue: 10652885.00
COV.V income_statement (annual, 2022-09-30) — Reconciled Depreciation: 1032808.00
COV.V cash_flow (annual, 2022-09-30) — Repayment Of Debt: -585184.00
COV.V cash_flow (annual, 2022-09-30) — Repurchase Of Capital Stock: -1726954.00
COV.V income_statement (annual, 2022-09-30) — Research And Development: 1365803.00
COV.V balance_sheet (annual, 2022-09-30) — Restricted Cash: 1370700.00
COV.V balance_sheet (annual, 2022-09-30) — Retained Earnings: -33905285.00
COV.V cash_flow (annual, 2022-09-30) — Sale Of PPE: 101668.00
COV.V income_statement (annual, 2022-09-30) — Selling And Marketing Expense: 6517242.00
COV.V income_statement (annual, 2022-09-30) — Selling General And Administration: 13205222.00
COV.V balance_sheet (annual, 2022-09-30) — Share Issued: 25287777.00
COV.V cash_flow (annual, 2022-09-30) — Stock Based Compensation: 211438.00
COV.V balance_sheet (annual, 2022-09-30) — Stockholders Equity: 24228761.00
COV.V balance_sheet (annual, 2022-09-30) — Tangible Book Value: 22951434.00
COV.V income_statement (annual, 2022-09-30) — Tax Effect Of Unusual Items: 0.00
COV.V income_statement (annual, 2022-09-30) — Tax Rate For Calcs: 0.00
COV.V balance_sheet (annual, 2022-09-30) — Total Assets: 30378081.00
COV.V balance_sheet (annual, 2022-09-30) — Total Capitalization: 24228761.00
COV.V balance_sheet (annual, 2022-09-30) — Total Debt: 2168641.00
COV.V balance_sheet (annual, 2022-09-30) — Total Equity Gross Minority Interest: 24228761.00
COV.V income_statement (annual, 2022-09-30) — Total Expenses: 27288718.00
COV.V balance_sheet (annual, 2022-09-30) — Total Liabilities Net Minority Interest: 6149320.00
COV.V balance_sheet (annual, 2022-09-30) — Total Non Current Assets: 3150024.00
COV.V balance_sheet (annual, 2022-09-30) — Total Non Current Liabilities Net Minority Interest: 1610464.00
COV.V income_statement (annual, 2022-09-30) — Total Other Finance Cost: 111590.00
COV.V balance_sheet (annual, 2022-09-30) — Working Capital: 22689201.00
COV.V income_statement (annual, 2023-09-30) — +Operating Expense: 18890339.00
COV.V income_statement (annual, 2023-09-30) — +Total Revenue: 26595286.00
COV.V balance_sheet (annual, 2023-09-30) — Accounts Receivable: 6162069.00
COV.V balance_sheet (annual, 2023-09-30) — Accumulated Depreciation: -2338867.00
COV.V balance_sheet (annual, 2023-09-30) — Additional Paid In Capital: 11436826.00
COV.V cash_flow (annual, 2023-09-30) — Amortization Cash Flow: 239315.00
COV.V cash_flow (annual, 2023-09-30) — Amortization Of Intangibles: 239315.00
COV.V cash_flow (annual, 2023-09-30) — Asset Impairment Charge: 0.00
COV.V income_statement (annual, 2023-09-30) — Basic Average Shares: 24783322.00
COV.V income_statement (annual, 2023-09-30) — Basic EPS: -0.18
COV.V cash_flow (annual, 2023-09-30) — Beginning Cash Position: 14061631.00
COV.V balance_sheet (annual, 2023-09-30) — Buildings And Improvements: 439837.00
COV.V cash_flow (annual, 2023-09-30) — Capital Expenditure: -1316517.00
COV.V balance_sheet (annual, 2023-09-30) — Capital Lease Obligations: 1562465.00
COV.V balance_sheet (annual, 2023-09-30) — Capital Stock: 42770879.00
COV.V balance_sheet (annual, 2023-09-30) — Cash And Cash Equivalents: 8794650.00
COV.V balance_sheet (annual, 2023-09-30) — Cash Cash Equivalents And Short Term Investments: 8794650.00
COV.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Financing Activities: -2156054.00
COV.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Investing Activities: -1451717.00
COV.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Operating Activities: -3184008.00
COV.V cash_flow (annual, 2023-09-30) — Cash Flow From Discontinued Operation: 1370700.00
COV.V cash_flow (annual, 2023-09-30) — Change In Inventory: -1043597.00
COV.V cash_flow (annual, 2023-09-30) — Change In Other Working Capital: -183175.00
COV.V cash_flow (annual, 2023-09-30) — Change In Payables And Accrued Expense: 692021.00
COV.V cash_flow (annual, 2023-09-30) — Change In Prepaid Assets: 1687013.00
COV.V cash_flow (annual, 2023-09-30) — Change In Receivables: -1470010.00
COV.V cash_flow (annual, 2023-09-30) — Change In Working Capital: -134573.00
COV.V cash_flow (annual, 2023-09-30) — Changes In Account Receivables: -1470010.00
COV.V cash_flow (annual, 2023-09-30) — Changes In Cash: -5421079.00
COV.V balance_sheet (annual, 2023-09-30) — Common Stock: 42770879.00
COV.V balance_sheet (annual, 2023-09-30) — Common Stock Equity: 18792817.00
COV.V cash_flow (annual, 2023-09-30) — Common Stock Payments: -1472286.00
COV.V income_statement (annual, 2023-09-30) — Cost Of Revenue: 12233447.00
COV.V balance_sheet (annual, 2023-09-30) — Current Assets: 21291313.00
COV.V balance_sheet (annual, 2023-09-30) — Current Capital Lease Obligation: 643385.00
COV.V balance_sheet (annual, 2023-09-30) — Current Debt And Capital Lease Obligation: 643385.00
COV.V balance_sheet (annual, 2023-09-30) — Current Deferred Liabilities: 80702.00
COV.V balance_sheet (annual, 2023-09-30) — Current Deferred Revenue: 80702.00
COV.V balance_sheet (annual, 2023-09-30) — Current Liabilities: 5188696.00
COV.V cash_flow (annual, 2023-09-30) — Depreciation: 730055.00
COV.V cash_flow (annual, 2023-09-30) — Depreciation Amortization Depletion: 969370.00
COV.V cash_flow (annual, 2023-09-30) — Depreciation And Amortization: 969370.00
COV.V income_statement (annual, 2023-09-30) — Diluted Average Shares: 24783322.00
COV.V income_statement (annual, 2023-09-30) — Diluted EPS: -0.18
COV.V income_statement (annual, 2023-09-30) — Diluted NI Availto Com Stockholders: -4460998.00
COV.V income_statement (annual, 2023-09-30) — EBIT: -4528500.00
COV.V income_statement (annual, 2023-09-30) — EBITDA: -3559130.00
COV.V cash_flow (annual, 2023-09-30) — Effect Of Exchange Rate Changes: 154098.00
COV.V cash_flow (annual, 2023-09-30) — End Cash Position: 8794650.00
COV.V cash_flow (annual, 2023-09-30) — Financing Cash Flow: -2156054.00
COV.V balance_sheet (annual, 2023-09-30) — Finished Goods: 5775340.00
COV.V balance_sheet (annual, 2023-09-30) — Foreign Currency Translation Adjustments: 2951395.00
COV.V cash_flow (annual, 2023-09-30) — Free Cash Flow: -4500525.00
COV.V cash_flow (annual, 2023-09-30) — Gain Loss On Sale Of PPE: 0.00
COV.V balance_sheet (annual, 2023-09-30) — Gains Losses Not Affecting Retained Earnings: 2951395.00
COV.V income_statement (annual, 2023-09-30) — General And Administrative Expense: 7404226.00
COV.V balance_sheet (annual, 2023-09-30) — Goodwill And Other Intangible Assets: 1791305.00
COV.V balance_sheet (annual, 2023-09-30) — Gross PPE: 4021642.00
COV.V income_statement (annual, 2023-09-30) — Gross Profit: 14361839.00
COV.V balance_sheet (annual, 2023-09-30) — Inventories Adjustments Allowances: -1938776.00
COV.V balance_sheet (annual, 2023-09-30) — Inventory: 5944534.00
COV.V balance_sheet (annual, 2023-09-30) — Invested Capital: 18792817.00
COV.V cash_flow (annual, 2023-09-30) — Investing Cash Flow: -1451717.00
COV.V cash_flow (annual, 2023-09-30) — Issuance Of Debt: 0.00
COV.V balance_sheet (annual, 2023-09-30) — Leases: 383351.00
COV.V balance_sheet (annual, 2023-09-30) — Long Term Capital Lease Obligation: 919080.00
COV.V balance_sheet (annual, 2023-09-30) — Long Term Debt And Capital Lease Obligation: 919080.00
COV.V cash_flow (annual, 2023-09-30) — Long Term Debt Issuance: 0.00
COV.V cash_flow (annual, 2023-09-30) — Long Term Debt Payments: -683768.00
COV.V balance_sheet (annual, 2023-09-30) — Machinery Furniture Equipment: 746627.00
COV.V cash_flow (annual, 2023-09-30) — Net Common Stock Issuance: -1472286.00
COV.V income_statement (annual, 2023-09-30) — Net Income: -4460998.00
COV.V income_statement (annual, 2023-09-30) — Net Income Common Stockholders: -4460998.00
COV.V income_statement (annual, 2023-09-30) — Net Income Continuous Operations: -4460998.00
COV.V income_statement (annual, 2023-09-30) — Net Income Discontinuous Operations: 0.00
COV.V income_statement (annual, 2023-09-30) — Net Income From Continuing And Discontinued Operation: -4460998.00
COV.V income_statement (annual, 2023-09-30) — Net Income From Continuing Operation Net Minority Interest: -4460998.00
COV.V cash_flow (annual, 2023-09-30) — Net Income From Continuing Operations: -4460998.00
COV.V income_statement (annual, 2023-09-30) — Net Income Including Noncontrolling Interests: -4460998.00
COV.V cash_flow (annual, 2023-09-30) — Net Intangibles Purchase And Sale: -821882.00
COV.V income_statement (annual, 2023-09-30) — Net Interest Income: 67502.00
COV.V cash_flow (annual, 2023-09-30) — Net Issuance Payments Of Debt: -683768.00
COV.V cash_flow (annual, 2023-09-30) — Net Long Term Debt Issuance: -683768.00
COV.V income_statement (annual, 2023-09-30) — Net Non Operating Interest Income Expense: 67502.00
COV.V cash_flow (annual, 2023-09-30) — Net Other Investing Changes: -135200.00
COV.V balance_sheet (annual, 2023-09-30) — Net PPE: 1682775.00
COV.V cash_flow (annual, 2023-09-30) — Net PPE Purchase And Sale: -494635.00
COV.V balance_sheet (annual, 2023-09-30) — Net Tangible Assets: 17001512.00
COV.V balance_sheet (annual, 2023-09-30) — Non Current Deferred Liabilities: 0.00
COV.V balance_sheet (annual, 2023-09-30) — Non Current Deferred Revenue: 0.00
COV.V income_statement (annual, 2023-09-30) — Normalized EBITDA: -3559130.00
COV.V income_statement (annual, 2023-09-30) — Normalized Income: -4460998.00
COV.V cash_flow (annual, 2023-09-30) — Operating Cash Flow: -3184008.00
COV.V income_statement (annual, 2023-09-30) — Operating Income: -4528500.00
COV.V income_statement (annual, 2023-09-30) — Operating Revenue: 26595286.00
COV.V balance_sheet (annual, 2023-09-30) — Ordinary Shares Number: 24669577.00
COV.V income_statement (annual, 2023-09-30) — Other Gand A: 7404226.00
COV.V balance_sheet (annual, 2023-09-30) — Other Intangible Assets: 1791305.00
COV.V cash_flow (annual, 2023-09-30) — Other Non Cash Items: -116961.00
COV.V balance_sheet (annual, 2023-09-30) — Other Non Current Assets: 135200.00
COV.V income_statement (annual, 2023-09-30) — Other Operating Expenses: 1904941.00
COV.V balance_sheet (annual, 2023-09-30) — Other Properties: 2451827.00
COV.V balance_sheet (annual, 2023-09-30) — Payables And Accrued Expenses: 4464609.00
COV.V balance_sheet (annual, 2023-09-30) — Prepaid Assets: 390060.00
COV.V income_statement (annual, 2023-09-30) — Pretax Income: -4460998.00
COV.V cash_flow (annual, 2023-09-30) — Proceeds From Stock Option Exercised: 0.00
COV.V balance_sheet (annual, 2023-09-30) — Properties: 0.00
COV.V cash_flow (annual, 2023-09-30) — Purchase Of Intangibles: -821882.00
COV.V cash_flow (annual, 2023-09-30) — Purchase Of PPE: -494635.00
COV.V balance_sheet (annual, 2023-09-30) — Raw Materials: 2107970.00
COV.V balance_sheet (annual, 2023-09-30) — Receivables: 6162069.00
COV.V income_statement (annual, 2023-09-30) — Reconciled Cost Of Revenue: 12233447.00
COV.V income_statement (annual, 2023-09-30) — Reconciled Depreciation: 969370.00
COV.V cash_flow (annual, 2023-09-30) — Repayment Of Debt: -683768.00
COV.V cash_flow (annual, 2023-09-30) — Repurchase Of Capital Stock: -1472286.00
COV.V income_statement (annual, 2023-09-30) — Research And Development: 1413278.00
COV.V balance_sheet (annual, 2023-09-30) — Restricted Cash: 0.00
COV.V balance_sheet (annual, 2023-09-30) — Retained Earnings: -38366283.00
COV.V cash_flow (annual, 2023-09-30) — Sale Of PPE: 0.00
COV.V income_statement (annual, 2023-09-30) — Selling And Marketing Expense: 8167894.00
COV.V income_statement (annual, 2023-09-30) — Selling General And Administration: 15572120.00
COV.V balance_sheet (annual, 2023-09-30) — Share Issued: 24669577.00
COV.V cash_flow (annual, 2023-09-30) — Stock Based Compensation: 559154.00
COV.V balance_sheet (annual, 2023-09-30) — Stockholders Equity: 18792817.00
COV.V balance_sheet (annual, 2023-09-30) — Tangible Book Value: 17001512.00
COV.V income_statement (annual, 2023-09-30) — Tax Effect Of Unusual Items: 0.00
COV.V income_statement (annual, 2023-09-30) — Tax Rate For Calcs: 0.00
COV.V balance_sheet (annual, 2023-09-30) — Total Assets: 24900593.00
COV.V balance_sheet (annual, 2023-09-30) — Total Capitalization: 18792817.00
COV.V balance_sheet (annual, 2023-09-30) — Total Debt: 1562465.00
COV.V balance_sheet (annual, 2023-09-30) — Total Equity Gross Minority Interest: 18792817.00
COV.V income_statement (annual, 2023-09-30) — Total Expenses: 31123786.00
COV.V balance_sheet (annual, 2023-09-30) — Total Liabilities Net Minority Interest: 6107776.00
COV.V balance_sheet (annual, 2023-09-30) — Total Non Current Assets: 3609280.00
COV.V balance_sheet (annual, 2023-09-30) — Total Non Current Liabilities Net Minority Interest: 919080.00
COV.V income_statement (annual, 2023-09-30) — Total Other Finance Cost: -67502.00
COV.V balance_sheet (annual, 2023-09-30) — Tradeand Other Payables Non Current: 0.00
COV.V balance_sheet (annual, 2023-09-30) — Working Capital: 16102617.00
COV.V income_statement (annual, 2024-09-30) — +Operating Expense: 16781692.00
COV.V income_statement (annual, 2024-09-30) — +Total Revenue: 31168532.00
COV.V balance_sheet (annual, 2024-09-30) — Accounts Receivable: 3645252.00
COV.V balance_sheet (annual, 2024-09-30) — Accumulated Depreciation: -2539935.00
COV.V balance_sheet (annual, 2024-09-30) — Additional Paid In Capital: 8322591.00
COV.V cash_flow (annual, 2024-09-30) — Amortization Cash Flow: 302367.00
COV.V cash_flow (annual, 2024-09-30) — Amortization Of Intangibles: 302367.00
COV.V cash_flow (annual, 2024-09-30) — Asset Impairment Charge: 175052.00
COV.V cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: -2438.00
COV.V income_statement (annual, 2024-09-30) — Basic Average Shares: 24270836.00
COV.V income_statement (annual, 2024-09-30) — Basic EPS: 0.11
COV.V cash_flow (annual, 2024-09-30) — Beginning Cash Position: 8794650.00
COV.V balance_sheet (annual, 2024-09-30) — Buildings And Improvements: 168453.00
COV.V cash_flow (annual, 2024-09-30) — Capital Expenditure: -416835.00
COV.V balance_sheet (annual, 2024-09-30) — Capital Lease Obligations: 901671.00
COV.V balance_sheet (annual, 2024-09-30) — Capital Stock: 51748095.00
COV.V balance_sheet (annual, 2024-09-30) — Cash And Cash Equivalents: 16746781.00
COV.V balance_sheet (annual, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 16746781.00
COV.V cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Financing Activities: 4972062.00
COV.V cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Investing Activities: -281635.00
COV.V cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Operating Activities: 3472985.00
COV.V cash_flow (annual, 2024-09-30) — Cash Flow From Discontinued Operation: 0.00
COV.V cash_flow (quarterly, 2024-09-30) — Cash Flow From Discontinued Operation: 0.00
COV.V cash_flow (annual, 2024-09-30) — Change In Inventory: -1604838.00
COV.V cash_flow (annual, 2024-09-30) — Change In Other Working Capital: -7982.00
COV.V cash_flow (annual, 2024-09-30) — Change In Payables And Accrued Expense: -1058192.00
COV.V cash_flow (annual, 2024-09-30) — Change In Prepaid Assets: -279771.00
COV.V cash_flow (annual, 2024-09-30) — Change In Receivables: 2659804.00
COV.V cash_flow (annual, 2024-09-30) — Change In Working Capital: -290979.00
COV.V cash_flow (annual, 2024-09-30) — Changes In Account Receivables: 2659804.00
COV.V cash_flow (annual, 2024-09-30) — Changes In Cash: 8163412.00
COV.V balance_sheet (annual, 2024-09-30) — Common Stock: 51748095.00
COV.V balance_sheet (annual, 2024-09-30) — Common Stock Equity: 27504608.00
COV.V cash_flow (annual, 2024-09-30) — Common Stock Payments: 0.00